COMPAMED Innovation Forum 2025: Pioneering Cancer Detection: From Early Diagnosis to Precision Medicine

Cancer diagnostics is at a pivotal stage where innovative technologies are redefining how we detect and treat diseases. From early diagnosis to personalized medicine, this field offers revolutionary approaches to provide better and faster care for patients. Advances in microfluidics, AI, and lab-on-a-chip technologies are driving this transformation, unlocking new possibilities for precision diagnostics.

Building on this development, the COMPAMED Innovation Forum 2025, held as a webinar on June 5 and organized by the IVAM Microtechnology Association in cooperation with Messe Düsseldorf, focused on the latest advances in cancer diagnostics. Participants took a forward-looking perspective, not only exploring emerging possibilities and trends in medical technology, but also looking ahead to COMPAMED, taking place in Halls 8a and 8b in Düsseldorf from November 17 to 20.

This international leading trade fair for the medical technology supply sector, held alongside MEDICA, the world’s largest medical trade show, features around 750 exhibiting companies, presenting the full spectrum of materials, microtechnology, components, and services for use in the medical technology industry.

The session is chaired by Jens Ebnet, M.D., M.Sc., D.E.S.A

Read more here → www.compamed.de